Swiss National Bank’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
84,300
+8,600
| +11% | +$150K | ﹤0.01% | 1959 |
|
|
2025
Q1 | $952K | Hold |
75,700
| – | – | ﹤0.01% | 2149 |
|
|
2024
Q4 | $799K | Hold |
75,700
| – | – | ﹤0.01% | 2296 |
|
|
2024
Q3 | $1.1M | Buy |
75,700
+9,700
| +15% | +$141K | ﹤0.01% | 2174 |
|
|
2024
Q2 | $562K | Hold |
66,000
| – | – | ﹤0.01% | 2394 |
|
|
2024
Q1 | $675K | Hold |
66,000
| – | – | ﹤0.01% | 2389 |
|
|
2023
Q4 | $362K | Sell |
66,000
-16,300
| -20% | -$89.3K | ﹤0.01% | 2511 |
|
|
2023
Q3 | $311K | Hold |
82,300
| – | – | ﹤0.01% | 2581 |
|
|
2023
Q2 | $551K | Buy |
+82,300
| New | +$551K | ﹤0.01% | 2518 |
|
|
2021
Q4 | – | Sell |
-23,100
| Closed | -$231K | – | 2747 |
|
|
2021
Q3 | $231K | Hold |
23,100
| – | – | ﹤0.01% | 2618 |
|
|
2021
Q2 | $714K | Buy |
+23,100
| New | +$714K | ﹤0.01% | 2574 |
|